Second Trial Participant Dies in Alzheimer's Drug Study

(MedPage Today) -- Days before the release of promising phase III trial data of lecanemab, an investigational anti-amyloid drug for early Alzheimer's disease, a death possibly linked to the treatment was reported.
An unpublished case report featured...